Education
About Us
Working with TipRanks
Follow Us
Surgical Science Sweden AB (SE:SUS)
:SUS
Earnings Data
Report Date
Feb 19, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.04Last Year’s EPS
0.71Same Quarter Last Year
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong growth and strategic achievements offset by significant challenges, particularly in currency impacts, U.S. sales, and the U.K. market. The highlights, including record-breaking revenue and strategic partnerships, were counterbalanced by lowlights such as gross margin decline and Intelligent Ultrasound losses.Company Guidance
Record-Breaking Revenue
Total sales reached an all-time high of SEK 264 million, growing by 14% compared to the same quarter last year, and by 19% when adjusted for currency effects.
Strong Growth in Europe
The European market showed the strongest growth with a 46% increase, driven by strong sales in countries such as the Czech Republic, Poland, and Portugal.
Prominent Partnerships for Certification Programs
Launched training programs with ASGE and European Academy of Gynecology Surgery, marking a major step towards standardization of certification using simulators.
Industry OEM Performance
Industry OEM sales increased by 20%, with development revenue up by 131% compared to the same quarter in 2024. Secured potentially the largest single deal in the company's history within medical device simulation.
Intuitive's Growth
Reported 19% procedure growth for the da Vinci system in the third quarter, with the installed base growing by 13%.
Cost Savings from Intelligent Ultrasound Acquisition
Achieved cost savings of approximately GBP 2.5 million annually following the acquisition and integration of Intelligent Ultrasound.
SE:SUS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:SUS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | kr84.15 | kr74.20 | -11.82% |
Aug 21, 2025 | kr100.00 | kr100.60 | +0.60% |
May 14, 2025 | kr143.00 | kr150.70 | +5.38% |
Feb 19, 2025 | kr188.80 | kr160.80 | -14.83% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Surgical Science Sweden AB (SE:SUS) report earnings?
Surgical Science Sweden AB (SE:SUS) is schdueled to report earning on Feb 19, 2026, TBA (Confirmed).
What is Surgical Science Sweden AB (SE:SUS) earnings time?
Surgical Science Sweden AB (SE:SUS) earnings time is at Feb 19, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Surgical Science Sweden AB stock?
The P/E ratio of Surgical Science Sweden AB is N/A.
What is SE:SUS EPS forecast?
SE:SUS EPS forecast for the fiscal quarter 2025 (Q4) is 1.04.